Could a simple inhaler help both lungs and heart in new COPD patients?

NCT ID NCT06072690

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether a dual bronchodilator (a combination inhaler) can improve breathing, heart function, and quality of life in people newly diagnosed with moderate-to-severe COPD. Researchers will measure changes in exercise capacity and lung function over 12 weeks. The trial aims to enroll 80 adults aged 40 and older who have a significant smoking history.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
dual bronchodilator (a combination of two inhaled drugs to open airways)
What this could lead to
If successful, this could show that starting with dual bronchodilation soon after diagnosis improves both lung function and heart health in COPD patients.
What could go wrong
This is a small, early-stage study with only 80 participants, so results may not apply to all COPD patients. The treatment is already approved, so the main question is whether it offers extra heart benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lithuanian University of Health Sciences

    RECRUITING

    Kaunas, Kaunas County, 44307, Lithuania

More trials for these conditions

Other studies related to the condition(s) this trial covers.